
Investors should be extremely cautious with Hims & Hers Health (HIMS) due to significant operational and governance risks. The stock has plummeted approximately 80% from its highs, signaling a severe loss of market confidence. A major red flag is the recent departure of the company's head of compliance, which raises serious questions about its internal controls and regulatory standing. These issues create substantial brand and reputation risks for the consumer healthcare company. Given the highly bearish sentiment, investors should consider avoiding this stock.